Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
3.030
+0.120 (4.12%)
Feb 2, 2026, 4:00 PM EST - Market closed
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $4.05 million as of February 2, 2026. Its market cap has increased by 11.44% in one year.
Market Cap
4.05M
Enterprise Value
375.73K
1-Year Change
11.44%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $4.05M, a decrease of -100.00%. That is a compound annual growth rate of -87.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 4.05M | 8.91% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 4.50M |
| GRI Bio | 4.34M |
| PMGC Holdings | 4.07M |
| Matinas BioPharma Holdings | 3.96M |
| Galmed Pharmaceuticals | 3.73M |
| XORTX Therapeutics | 3.54M |
| Oragenics | 3.50M |
| SciSparc | 3.48M |